RANKL Antikörper (Biotin)

Produktnummer ABIN288465

Der Biotin-konjugierte Ziege Polyklonal anti-RANKL Antikörper (ABIN288465) detektiert spezifisch RANKL in WB, ELISA und InhibAb. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für RANKL Antikörper (Biotin) (ABIN288465)

Target: RANKL (TNFSF11) (Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11))

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser RANKL Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), ELISA, Blocking Antibody (InhibAb)

Produktdetails anti-RANKL Antikörper (Biotin)

Immunogen: sRANKL antibody (biotin) was raised in goat using highly pure recombinant human sRANKL as the immunogen.

Anwendungsinformationen

Applikationshinweise: ELISA: 0.25-1 µg/mL, WB: 0.1-0.2 µg/mL
Optimal conditions should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute to a concentration of 50 µg/mL with sterile PBS solution containing 0.1 % BSA.

Konzentration: Lot specific

Buffer: Lyophilized from PBS, pH 7.2.

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.

Details zu RANKL

Target: RANKL (TNFSF11) (Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11))

Andere Bezeichnung: sRANKL

Hintergrund: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T-cell proliferation in a mixed lymphocyte reaction, to promote the survival of RANK + T cells, and to regulate T-cell-dependent immune response.

Pathways: NF-kappaB Signalweg